[go: up one dir, main page]

Respiratory Distress Syndrome, Newborn

"Respiratory Distress Syndrome, Newborn" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.


expand / collapse Publications
This graph shows the total number of publications written about "Respiratory Distress Syndrome, Newborn" by people in this website by year, and whether "Respiratory Distress Syndrome, Newborn" was a major or minor topic of these publications.
Below are the most recent publications written about "Respiratory Distress Syndrome, Newborn" by people in Profiles.
  1. Use of neonatal lung ultrasound in European neonatal units: a survey by the European Society of Paediatric Research. Arch Dis Child Fetal Neonatal Ed. 2024 Oct 18; 109(6):660-664.
    View in: PubMed
  2. Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol. 2024 Dec 01; 327(6):L883-L889.
    View in: PubMed
  3. Risk factors, incidence, and outcomes of neonatal respiratory extracorporeal membrane oxygenation including association with therapeutic hypothermia in California during 2013-2020. J Perinatol. 2024 Oct; 44(10):1442-1447.
    View in: PubMed
  4. Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial). Trials. 2024 Jul 02; 25(1):433.
    View in: PubMed
  5. Life-saving effect of pulmonary surfactant in premature babies. J Clin Invest. 2024 May 01; 134(9).
    View in: PubMed
  6. Use of surfactant beyond respiratory distress syndrome, what is the evidence? J Perinatol. 2024 Apr; 44(4):478-487.
    View in: PubMed
  7. Pneumothorax in a term newborn. J Perinatol. 2024 Apr; 44(4):465-471.
    View in: PubMed
  8. Should nasal respiratory support in preterm infants be tailored for physiologic maturity? Pediatr Res. 2024 May; 95(6):1402-1403.
    View in: PubMed
  9. Caffeine and Less Invasive Surfactant Administration for Respiratory Distress Syndrome of the Newborn. NEJM Evid. 2023 Dec; 2(12):EVIDoa2300183.
    View in: PubMed
  10. Optimal timing of delivery for growth restricted fetuses with gastroschisis: A decision analysis. Prenat Diagn. 2023 11; 43(12):1506-1513.
    View in: PubMed